Recall issued for blood pressure medication over possible cholesterol drug contamination

article

FILE - In this photo illustration, the Glenmark Pharmaceuticals company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

A nationwide recall has been issued for thousands of bottles of blood-pressure medication due to the possibility of cross-contamination with another drug. 

Ziac recall

Dig deeper:

The U.S. Food and Drug Administration issued a recall for the blood pressure medication last week on Dec. 1 after testing revealed that "trace amounts of ezetimibe," a prescription drug used to treat high cholesterol, were detected in reserve samples. 

The FDA added that the recall affects 30-count bottles (NDC 68462-878-30), 100-count bottles (NDC 68462-878-01) and 500-count bottles (NDC 68462-878-05).

The recalled lot numbers carry expiration dates ranging from November 2025 to May 2026, the agency said.

By the numbers:

Roughly 11,100 bottles of the combination medication bisoprolol fumarate and hydrochlorothiazide, sold under the brand name Ziac, were involved in the recall. 

The pills come in 2.5-milligram and 6.25-milligram doses and are manufactured by Glenmark Pharmaceuticals, a company based in Elmwood Park, New Jersey. 

Neither Glenmark nor the FDA have issued guidance on what to do if consumers have purchased the medication included in this recall, according to a USA Today report.